Genome Sequence and Assessment of Safety and Potential Probiotic Traits of Lactobacillus johnsonii CNCM I-4884
- 2022-01-25
- Microorganisms 10(2)
- Anne-Sophie Boucard
- I. Florent
- B. Polack
- P. Langella
- L. Bermúdez-Humarán
- PubMed: 35208728
- DOI: 10.3390/microorganisms10020273
- Low evidence
- Rigorous Journal
The probiotic strain Lactobacillus johnsonii CNCM I-4884 exhibits anti-Giardia activity in vitro and in vivo in a murine model of giardiasis.
- Effect
- Beneficial
- Effect size
- Moderate